NOV.DE vs. NOVO-B.CO
Compare and contrast key facts about Novo Nordisk A/S (NOV.DE) and Novo Nordisk A/S (NOVO-B.CO).
Performance
NOV.DE vs. NOVO-B.CO - Performance Comparison
Loading graphics...
NOV.DE vs. NOVO-B.CO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NOV.DE Novo Nordisk A/S | -25.88% | -45.91% | -9.75% | 49.59% | 30.57% | 73.65% | 13.34% | 35.40% | 19.47% | 34.91% |
NOVO-B.CO Novo Nordisk A/S | -24.70% | -46.44% | -9.91% | 50.83% | 29.14% | 76.14% | 13.26% | 32.53% | -8.71% | 35.09% |
Different Trading Currencies
NOV.DE is traded in EUR, while NOVO-B.CO is traded in DKK. To make them comparable, the NOVO-B.CO values have been converted to EUR using the latest available exchange rates.
Returns By Period
The year-to-date returns for both investments are quite close, with NOV.DE having a -25.88% return and NOVO-B.CO slightly higher at -24.63%. Over the past 10 years, NOV.DE has outperformed NOVO-B.CO with an annualized return of 7.88%, while NOVO-B.CO has yielded a comparatively lower 5.25% annualized return.
NOV.DE
- 1D
- 0.75%
- 1M
- 4.46%
- YTD
- -25.88%
- 6M
- -34.37%
- 1Y
- -47.29%
- 3Y*
- -22.45%
- 5Y*
- 4.02%
- 10Y*
- 7.88%
NOVO-B.CO
- 1D
- 2.73%
- 1M
- 5.97%
- YTD
- -24.63%
- 6M
- -33.93%
- 1Y
- -46.96%
- 3Y*
- -22.22%
- 5Y*
- 4.03%
- 10Y*
- 5.25%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NOV.DE vs. NOVO-B.CO — Risk / Return Rank
NOV.DE
NOVO-B.CO
NOV.DE vs. NOVO-B.CO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOV.DE) and Novo Nordisk A/S (NOVO-B.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NOV.DE | NOVO-B.CO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.87 | -0.88 | +0.01 |
Sortino ratioReturn per unit of downside risk | -1.09 | -1.12 | +0.03 |
Omega ratioGain probability vs. loss probability | 0.85 | 0.85 | 0.00 |
Calmar ratioReturn relative to maximum drawdown | -0.84 | -0.87 | +0.03 |
Martin ratioReturn relative to average drawdown | -1.42 | -1.48 | +0.06 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| NOV.DE | NOVO-B.CO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.87 | -0.88 | +0.01 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.11 | 0.11 | 0.00 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.24 | 0.16 | +0.07 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.48 | 0.47 | 0.00 |
Correlation
The correlation between NOV.DE and NOVO-B.CO is 0.80, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
NOV.DE vs. NOVO-B.CO - Dividend Comparison
NOV.DE's dividend yield for the trailing twelve months is around 4.96%, which matches NOVO-B.CO's 4.94% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOV.DE Novo Nordisk A/S | 4.96% | 3.54% | 1.58% | 1.01% | 1.17% | 1.27% | 1.99% | 2.09% | 27.20% | 2.27% | 3.67% | 1.25% |
NOVO-B.CO Novo Nordisk A/S | 4.94% | 3.58% | 1.59% | 1.01% | 1.19% | 1.27% | 2.02% | 2.11% | 2.64% | 2.27% | 3.69% | 1.25% |
Drawdowns
NOV.DE vs. NOVO-B.CO - Drawdown Comparison
The maximum NOV.DE drawdown since its inception was -76.64%, roughly equal to the maximum NOVO-B.CO drawdown of -76.81%. Use the drawdown chart below to compare losses from any high point for NOV.DE and NOVO-B.CO.
Loading graphics...
Drawdown Indicators
| NOV.DE | NOVO-B.CO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.64% | -76.75% | +0.11% |
Max Drawdown (1Y)Largest decline over 1 year | -54.59% | -54.94% | +0.35% |
Max Drawdown (5Y)Largest decline over 5 years | -76.64% | -76.75% | +0.11% |
Max Drawdown (10Y)Largest decline over 10 years | -76.64% | -76.75% | +0.11% |
Current DrawdownCurrent decline from peak | -75.60% | -75.38% | -0.22% |
Average DrawdownAverage peak-to-trough decline | -12.35% | -15.80% | +3.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 32.08% | 32.14% | -0.06% |
Volatility
NOV.DE vs. NOVO-B.CO - Volatility Comparison
The current volatility for Novo Nordisk A/S (NOV.DE) is 7.06%, while Novo Nordisk A/S (NOVO-B.CO) has a volatility of 9.13%. This indicates that NOV.DE experiences smaller price fluctuations and is considered to be less risky than NOVO-B.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| NOV.DE | NOVO-B.CO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.06% | 9.13% | -2.07% |
Volatility (6M)Calculated over the trailing 6-month period | 39.95% | 40.82% | -0.87% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.43% | 55.46% | -1.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 37.51% | 38.38% | -0.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.16% | 32.54% | +0.62% |
Financials
NOV.DE vs. NOVO-B.CO - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities